The FDA has approved Innocoll's application to conduct a phase II study for CollaRx Gentamicin as a topical antibiotic treatment for mildly infected diabetic foot ulcers. CollaRx Gentamicin is a Gentamicin-Collagen Sponge formulated and manufactured using Innocoll's proprietary CollaRx technology.